1. Home
  2. NBTX vs RNP Comparison

NBTX vs RNP Comparison

Compare NBTX & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$51.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

HOLD

Current Price

$20.45

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTX
RNP
Founded
2003
2003
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NBTX
RNP
Price
$51.00
$20.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
68.3K
78.0K
Earning Date
03-31-2026
01-01-0001
Dividend Yield
N/A
7.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$58.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.64
$19.27
52 Week High
$57.14
$22.99

Technical Indicators

Market Signals
Indicator
NBTX
RNP
Relative Strength Index (RSI) 65.31 40.03
Support Level $19.22 $19.90
Resistance Level N/A $20.55
Average True Range (ATR) 3.29 0.26
MACD 1.71 -0.06
Stochastic Oscillator 77.12 1.49

Price Performance

Historical Comparison
NBTX
RNP

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

Share on Social Networks: